Influence of platelet count, acetylsalicylic acid, von Willebrand's Disease, coagulopathies, and haematocrit on results obtained using a platelet function analyser in dogs

Veterinary Journal

Volumn 165, Issue 1, 2003, Pages 43-52

  Mischke, Reinhard ^a   Keidel, A ^a  

^a UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

Author keywords

Acetylsalicylic acid; Coagulopathies; Dog; Haematocrit; Platelet count; Platelet function analyser; von Willebrand's disease

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; ADRENALIN; COLLAGEN;

ANALYZER; ARTICLE; ASPIRATION; BLEEDING TIME; BLOOD CLOTTING DISORDER; CONTROLLED STUDY; CORRELATION ANALYSIS; DISPOSABLE EQUIPMENT; DOG; FEMALE; HEMATOCRIT; IN VITRO STUDY; MALE; MATERIAL COATING; NONHUMAN; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION; THROMBOCYTOPENIA; VON WILLEBRAND DISEASE; ANIMAL; ANIMAL DISEASE; BLOOD CLOTTING PARAMETERS; DOG DISEASE; INSTRUMENTATION; REFERENCE VALUE; TIME;

CANIS FAMILIARIS;

ANIMALS; ASPIRIN; BLOOD COAGULATION DISORDERS; DOG DISEASES; DOGS; FEMALE; HEMATOCRIT; MALE; PLATELET COUNT; PLATELET FUNCTION TESTS; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; TIME FACTORS; VON WILLEBRAND DISEASE;

EID: 0038657739     PISSN: 10900233     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1090-0233(02)00169-7     Document Type: Article

References (35)

1. Born G.V.R. Aggregation of blood platelets by adenosine diphosphate and its reversal Nature 194 1962 927-929
2. Carcao M.D. Blanchette V.S. Dean J.A. He L. Kern M.A. Stain A.M. Sparling C.R. Stephens D. Ryan G. Freedman J. Rand M.L. The platelet function analyzer (PFA-100): a novel in vitro system for evaluation of primary haemostasis in children British Journal of Haematology 101 1998 70-73
3. Cattaneo M. Federici A.B. Lecchi A. Agati B. Lombardi R. Stabile F. Bucciarelli P. Evaluation of the PFA-100® system in the diagnosis and therapeutic monitoring of patients with von Willebrand diesease Thrombosis and Haemostasis 82 1999 35-39
4. Cattaneo M. Lecchi A. Agati B. Lombardi R. Zighetti M.L. Evaluation of platelet function with the PFA-100 system in patients with congenital defects of platelet secretion Thrombosis Research 96 1999 213-217
5. Dean J.A. Blanchette V.S. Carcao M.D. Stain A.M. Sparling C.R. Siekmann J. Turecek P.L. Lillicrap D. Rand M.L. Von Willebrand disease in a pediatric-based population-comparison of type 1 diagnostic criteria and use of the PFA-100® and a von Willebrand factor/collagen-binding assay Thrombosis and Haemostasis 84 2000 401-409
6. Dietrich G.V. Kretschmer V. Weber D. Haupt W. Langen B. Huss B. Variables influencing the Thrombostat 4000: recommended standardization Seminars in Thrombosis and Hemostasis 21 Suppl. II 1995 11-19
7. 1 levels in type I von Willebrand disease correlate with impaired platelet function in a high shear stress system Blood 93 1999 3578-3582
8. Escolar G. Cases A. Vinas M. Pino M. Calls J. Cirera I. Ordinas A. Evaluation of acquired platelet dysfunctions in uremic and cirrhotic patients using the platelet function analyzer (PFA-100): influence of hematocrit elevation Haematologica 84 1999 614-619
9. Favaloro E.J. Facey D. Henniker A. Use of a novel platelet function analyzer (PFA-100™ with high sensitivity to disturbances in von Willebrand factor to screen for von Willebrand's disease and other disorders American Journal of Hematology 62 1999 165-174
10. Feingold H.M. Pivacek L.E. Melaragno A.J. Valeri R. Coagulation assays and platelet aggregation patterns in human, baboon and canine blood American Journal of Veterinary Research 47 1986 2197-2199
11. Fressinaud E. Veyradier A. Truchaud F. Martin I. Boyer-Neumann C. Trossaert M. Meyer D. Screening for von Willebrand disease with a new analyzer using high shear stress: a study of 60 cases Blood 91 1998 1325-1331
12. Gentry P.A. Platelet biology In: Feldman B.F. Zinkl J.G. Jain N.C. (eds.) Schalm's Veterinary Hematology 5th ed. 2000 459-466 Lippincott Williams & Wilkins Philadelphia, Baltimore
13. Harrison P. Robinson M.S.C. Mackie I.J. Joseph J. Mcdonald S.J. Liesner R. Savidge G.F. Pasi J. Machin S.J. Performance of the platelet function analyzer PFA-100® in testing abnormalities of primary haemostasis Blood Coagulation and Fibrinolysis 10 1999 25-31
14. Hézard N. Metz D. Nazeyrollas P. Droulle C. Elaerts J. Potron G. Nguyen P. Use of the PFA-100™ apparatus to assess platelet function in patients undergoing PTCA during and after infusion of cE3 Fab in the presence of other antiplatelet agents Thrombosis and Haemostasis 83 2000 540-544
15. Homoncik M. Jilma B. Hergovich N. Stohlawetz P. Panzer S. Speiser W. Monitoring of Aspirin (ASA) pharmacodynamics with the platelet function analyzer PFA-100 Thrombosis and Haemostasis 83 2000 316-321
16. Jergens A.E. Turrentine M.A. Kraus K.H. Johnson G.S. Buccal mucosa bleeding times of healthy dogs and of dogs in various pathologic states, including thrombocytopenia, uremia, and von Willebrand's disease American Journal of Veterinary Research 48 1987 1337-1342
17. Johnstone I.B. Crane S. The effects of desmopressin on plasma factor VIII/von Willebrand factor activity in dogs with von Willebrand's disease Canadian Journal of Veterinary Research 51 1987 189-193
18. Kaufmann J.E. Oksche A. Wollheim C.B. Günther G. Rosenthal W. Vischer U.M. Vasopressin-induced von Willebrand factor secretion from endothelial cells involves V2 receptors and cAMP The Journal of Clinical Investigation 106 2000 107-116
19. Karger R. Gutensohn K. Böck M. Beck K.-H. Hertfelder H.-J. Kretschmer V. PFA-100 closure time. Reference range for blood in 3.2% buffered citrate Infusionstherapie und Transfusionsmedizin 24 1997 303 (Abstr. F/G-442)
20. Keidel A. Mischke R. Untersuchungen zur klinischen Anwendung des Plättchenfunktionsanalysengerätes PFA-100 beim Hund Berliner und Münchener Tierärztliche Wochenschrift 111 1998 452-456
21. Kretschmer V. Huss B. Dietrich G. Heymanns J. Pflüger K.-H. Determination of bleeding risk in thrombocytopenic patients receiving platelet substitution Transfusion Science 14 1993 27-34
22. Kretschmer V. Huss B. Bonacker G. Hoffmann J. Bewarder S. Weber S. Schulzki T. Köppler H. Heimanns J. Thrombocytopenia-adapted in vitro bleeding test assesses platelet function in thrombocytopenic patients Seminars in Thrombosis and Hemostasis 21 Suppl. II 1995 79-90
23. Kristensen A.T. Weiss D.J. Klausner J.S. Platelet dysfunction associated with immune-mediated thrombocytopenia in dogs Journal of Veterinary Internal Medicine 8 1994 323-327
24. Kundu S.K. Heilmann E.J. Sio R. Garcia C. Davidson R.M. Ostgaard R.A. Description of an in vitro platelet function analyzer-PFA-100™ Seminars in Thrombosis and Hemostasis 21 Suppl. 2 1995 106-112
25. Kundu S.K. Heilmann E.J. Sio R. Garcia C. Ostgaard R.A. Characterization of an in vitro platelet function analyzer, PFA-100™ Clinical and Applied Thrombosis/Hemostasis 2 1996 241-249
26. Mammen E.F. Comp P.C. Gosselin R. Greenberg C. Hoots W.K. Kessler C.M. Larkin E.C. Liles D. Nugent D.J. PFA™-100 system: a new method for assessment of platelet dysfunction Seminars in Thrombosis and Hemostasis 24 1998 195-202
27. Mannucci P.M. Ruggeri Z.M. Pareti F.I. Capitanio A. 1-Deamino-8-d arginine vasopressin: a new pharmacological approach to the management of haemophilia and von Willebrand's diseases Lancet 1 1977 869-872
28. Meyers K.M. Wardrop K.-J. Dodds W.J. Brassard J. Effect of exercise, DDAVP, and epinephrine on the factor VIII:C/von Willebrand factor complex in normal dogs and von Willebrand factor deficient Dobermann pinscher dogs Thrombosis Research 57 1990 97-108
29. Nolte I. Niemann C. Bowry S.K. Failing K. Müller-Berghaus G. A method for measuring capillary bleeding time in non-anaesthetized dogs: prolongation of bleeding time by acetylsalicylic acid Journal of Veterinary Medicine Series A 44 1997 625-628
30. Ortel T.L. James A.H. Thames E.H. Moore K.D. Greenberg C.S. Assessment of primary hemostasis by PFA-100 analysis in a tertiary care center Thrombosis and Haemostsis 84 2000 93-97
31. Rand M.L. Carcao M.D. Blanchette V.S. Use of the PFA-100® in the assessment of primary, platelet-related hemostasis in a pediatric setting Seminars in Thrombosis and Hemostasis 24 1998 523-529
32. Schwarz H.P. Turecek P.L. Pichler L. Mitterer A. Mundt W. Dorner F. Roussi J. Drouet L. Recombinant von Willebrand factor Thrombosis and Haemostasis 78 1997 571-576
33. Sestito A. Sciahbasi A. Landolfi R. Maseri A. Lanza G.A. Andreotti F. A simple assay for platelet-mediated hemostasis in flowing whole blood (PFA-100): reproducibility and effects of sex and age Cardiologia 44 1999 661-665
34. Söhngen D. Hattstein E. Heyll A. Meckenstock G. Wienen S. Schneider W. Hematological parameters inluencing the Thrombostat 4000 Seminars in Thrombosis and Hemostasis 21 Suppl. II 1995 20-24
35. Weippert-Kretschmer M. Witte M. Budde U. Vigh T. Kretschmer V. Scharrer I. The Thrombostat 4000-a sensitive screening test for von Willebrand's disease (vWD) Seminars in Thrombosis and Hemostasis 21 Suppl. II 1995 44-51